SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krebs Biochemicals & Industries informs about closure of trading window

23 Sep 2024 Evaluate

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, Krebs Biochemicals & Industries has informed that the trading window for dealings in securities of the Company shall remain closed with effect from close of business hours on 30th September 2024 un-till 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended 30th September 2024 for promoters, directors, designated persons, their immediate relatives and all connected persons covered under the said code. The date of the Board meeting for consideration of the said Unaudited Financial Results would be intimated to the stock exchanges in due course of time.

The above information is a part of company’s filings submitted to BSE.

Krebs Biochem.&Inds Share Price

56.60 1.69 (3.08%)
13-Jul-2026 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1927.20
Dr. Reddys Labs. 1227.00
Cipla 1425.00
Zydus Lifesciences 1134.00
Lupin 2496.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: